<?xml version="1.0" encoding="iso-8859-1"?>
<rss version="2.0">
<channel>
	<title>nyheter om biotech och life science</title>
	<link>http://biotech.idg.se</link>
	<description>Nyheter Biotech Sweden</description>

	<language>sv</language>
	<lastBuildDate>Wed, 16 May 2012 19:26:31 +0200</lastBuildDate>
	<copyright>Copyright 1998-2010 INTERNATIONAL DATA GROUP. All Rights Reserved.</copyright>
	<webMaster>webmaster@idg.se (IDG Webmaster)</webMaster>
    <item>
	<guid>http://biotech.idg.se/2.1763/1.449115/battre-forsvar-mot-influensa</guid><title>B&#228;ttre f&#246;rsvar mot influensa </title>
		<description>&#60;img src=&#34;http://biotech.idg.se/polopoly_fs/1.449115.1337168712!teaserImage/imageTypeSelector/localImage/1260672556.jpg&#34; border=&#34;0&#34;&#62;&#60;br&#62;Adjuvans f&#246;rst&#228;rker vaccin mot s&#228;songsinfluensa enligt ny studie.</description>
		<link>http://biotech.idg.se/2.1763/1.449115/battre-forsvar-mot-influensa</link>
		<pubDate>Wed, 16 May 2012 11:20:18 +0200</pubDate>
		<category>Biotech Sweden</category>
		<category>Forskning</category>
		<category>Kliniska studier</category>
		<category>Bioteknik</category>
		<category>Ekonomi/Branch</category>
		<category>matrix m</category>
		<category>vaxigrip</category>
		<category>sanofi pasteur</category>
		<category>cd4</category>
		<category>isconova</category>
		</item>
<item>
	<guid>http://biotech.idg.se/2.1763/1.449226/fortroendet-for-lakemedelsverkets-ledning-sjunker</guid><title>F&#246;rtroendet f&#246;r ledningen sjunker </title>
		<description>&#60;img src=&#34;http://biotech.idg.se/polopoly_fs/1.449226.1337177894!teaserImage/imageTypeSelector/localImage/488830751.jpg&#34; border=&#34;0&#34;&#62;&#60;br&#62;En f&#228;rsk medarbetarunders&#246;kning p&#229; L&#228;kemedelsverket visar att h&#228;lften av de anst&#228;llda saknar f&#246;rtroende f&#246;r ledningen.</description>
		<link>http://biotech.idg.se/2.1763/1.449226/fortroendet-for-lakemedelsverkets-ledning-sjunker</link>
		<pubDate>Wed, 16 May 2012 14:55:05 +0200</pubDate>
		<category>Biotech Sweden</category>
		<category>Jobb &#38; Karri&#228;r</category>
		<category>Bioteknik</category>
		<category>Ekonomi/Branch</category>
		<category>l&#228;kemedelsverket</category>
		<category>kritik</category>
		<category>ledning</category>
		<category>f&#246;rtroende</category>
		</item>
<item>
	<guid>http://biotech.idg.se/2.1763/1.449066/chef-pa-termo-fischer-scientific-rankas-fyra-bland-framtidens-kvinnliga-ledare</guid><title>Framtidens ledare</title>
		<description>&#60;img src=&#34;http://biotech.idg.se/polopoly_fs/1.449066.1337168719!teaserImage/imageTypeSelector/localImage/1898237217.jpg&#34; border=&#34;0&#34;&#62;&#60;br&#62;Rankas p&#229; plats fyra av chefsorganisationen Ledarna. </description>
		<link>http://biotech.idg.se/2.1763/1.449066/chef-pa-termo-fischer-scientific-rankas-fyra-bland-framtidens-kvinnliga-ledare</link>
		<pubDate>Wed, 16 May 2012 13:45:42 +0200</pubDate>
		<category>Biotech Sweden</category>
		<category>Jobb &#38; Karri&#228;r</category>
		<category>Bioteknik</category>
		<category>Ekonomi/Branch</category>
		<category>termo fischer scientific</category>
		</item>
<item>
	<guid>http://biotech.idg.se/2.1763/1.448996/vardmyndigheter-slas-samman</guid><title>V&#229;rdmyndigheter sl&#229;s samman</title>
		<description>&#60;img src=&#34;http://biotech.idg.se/polopoly_fs/1.448996.1337154698!teaserImage/imageTypeSelector/localImage/670952914.jpg&#34; border=&#34;0&#34;&#62;&#60;br&#62;Tolv av dagens myndigheter och organisationer verksamma inom v&#229;rd och omsorg kan komma att l&#228;ggas ned och ers&#228;ttas av fyra nya myndigheter. </description>
		<link>http://biotech.idg.se/2.1763/1.448996/vardmyndigheter-slas-samman</link>
		<pubDate>Tue, 15 May 2012 17:07:02 +0200</pubDate>
		<category>Biotech Sweden</category>
		<category>Bransch</category>
		<category>Bioteknik</category>
		<category>Ekonomi/Branch</category>
		<category>apoteket</category>
		<category>kunskapsmyndigheten</category>
		<category>inspektionen</category>
		<category>infrastrukturmyndigheten</category>
		<category>l&#228;kemedelsverket</category>
		<category>christina &#229;kerman</category>
		<category>stefan carlsson</category>
		</item>
<item>
	<guid>http://biotech.idg.se/2.1763/1.448862/fler-jobb-forsvinner-fran-astra-zeneca</guid><title>Fler jobb f&#246;rsvinner </title>
		<description>&#60;img src=&#34;http://biotech.idg.se/polopoly_fs/1.448862.1337079122!teaserImage/imageTypeSelector/localImage/3910413999.jpg&#34; border=&#34;0&#34;&#62;&#60;br&#62;Ytterligare 400 tj&#228;nster ska bort fr&#229;n Astra Zeneca i S&#246;dert&#228;lje. </description>
		<link>http://biotech.idg.se/2.1763/1.448862/fler-jobb-forsvinner-fran-astra-zeneca</link>
		<pubDate>Tue, 15 May 2012 11:14:39 +0200</pubDate>
		<category>Biotech Sweden</category>
		<category>Jobb &#38; Karri&#228;r</category>
		<category>Bioteknik</category>
		<category>Ekonomi/Branch</category>
		<category>astra zeneca</category>
		<category>s&#246;dert&#228;lje</category>
		<category>jobb</category>
		<category>forskare</category>
		<category>l&#228;kemedel</category>
		<category>life science</category>
		</item>
<item>
	<guid>http://biotech.idg.se/2.1763/1.448470/patienterna-nobbar-virtuell-provning</guid><title>Patienterna nobbar  virtuell pr&#246;vning</title>
		<description>&#60;img src=&#34;http://biotech.idg.se/polopoly_fs/1.448470.1336979506!teaserImage/imageTypeSelector/localImage/2617346489.jpg&#34; border=&#34;0&#34;&#62;&#60;br&#62;F&#246;rra sommaren lanserade Pfizer v&#228;rldens f&#246;rsta helt virtuella kliniska pr&#246;vning i USA. Men patienterna svek. Nu ska de i st&#228;llet testa samma koncept i Europa.&#160;</description>
		<link>http://biotech.idg.se/2.1763/1.448470/patienterna-nobbar-virtuell-provning</link>
		<pubDate>Mon, 14 May 2012 07:05:00 +0200</pubDate>
		<category>Biotech Sweden</category>
		<category>Forskning</category>
		<category>Kliniska studier</category>
		<category>Bioteknik</category>
		<category>Ekonomi/Branch</category>
		<category>pfizer</category>
		<category>bj&#246;rn brag&#233;e</category>
		<category>cro</category>
		<category>forskarpatient.se</category>
		<category>remote</category>
		<category>fda</category>
		<category>miguel orri</category>
		<category>bragee medect clinical trial</category>
		<category>tillv&#228;xtverket</category>
		<category>forskningspatient.se</category>
		<category>sm&#228;rtguiden</category>
		</item>
<item>
	<guid>http://biotech.idg.se/2.1763/1.448651/studie-om-modifierat-h5n1-virus-publicerad</guid><title>Studie om modifierat H5N1-virus publicerad</title>
		<description>&#60;img src=&#34;http://biotech.idg.se/polopoly_fs/1.448651.1336992748!teaserImage/imageTypeSelector/localImage/1696021226.jpg&#34; border=&#34;0&#34;&#62;&#60;br&#62;Amerikansk s&#228;kerhetsmyndighet kunde inte stoppa den.</description>
		<link>http://biotech.idg.se/2.1763/1.448651/studie-om-modifierat-h5n1-virus-publicerad</link>
		<pubDate>Mon, 14 May 2012 12:48:49 +0200</pubDate>
		<category>Biotech Sweden</category>
		<category>Forskning</category>
		<category>Bioteknik</category>
		<category>Ekonomi/Branch</category>
		<category>h5n1</category>
		<category>biotech sweden</category>
		<category>nsabb</category>
		<category>nature</category>
		<category>science</category>
		<category>sveriges radio</category>
		</item>
<item>
	<guid>http://biotech.idg.se/2.1763/1.448413/bactiguard-forstarker-styrelsen</guid><title>Bactiguard st&#228;rker bolagsstyrelsen</title>
		<description>&#60;img src=&#34;http://biotech.idg.se/polopoly_fs/1.448413.1336992631!teaserImage/imageTypeSelector/localImage/2573213218.jpg&#34; border=&#34;0&#34;&#62;&#60;br&#62;Tar in tv&#229; nya ledam&#246;ter.</description>
		<link>http://biotech.idg.se/2.1763/1.448413/bactiguard-forstarker-styrelsen</link>
		<pubDate>Mon, 14 May 2012 07:09:00 +0200</pubDate>
		<category>Biotech Sweden</category>
		<category>Jobb &#38; Karri&#228;r</category>
		<category>Bioteknik</category>
		<category>Ekonomi/Branch</category>
		<category>bactiguard</category>
		<category>ewa st&#228;lldal</category>
		<category>ulf mattsson</category>
		<category>gambro</category>
		<category>karolinska institutet</category>
		<category>capio</category>
		<category>m&#246;lnlycke health care</category>
		<category>academedia</category>
		<category>thomas von koch</category>
		<category>christian kinch</category>
		<category>tomas puusepp</category>
		</item>
<item>
	<guid>http://biotech.idg.se/2.1763/1.448202/antalet-studier-i-klinisk-fas-i-minskar</guid><title>Antalet studier i klinisk fas I minskar </title>
		<description>&#60;img src=&#34;http://biotech.idg.se/polopoly_fs/1.448202.1336738617!teaserImage/imageTypeSelector/localImage/4074292658.jpg&#34; border=&#34;0&#34;&#62;&#60;br&#62;Minskningen drabbar b&#229;de v&#229;rden, patienterna och f&#246;retagen i Sverige, p&#229;pekar Lif:s vd Anders Blanck som oroas &#246;ver utvecklingen.</description>
		<link>http://biotech.idg.se/2.1763/1.448202/antalet-studier-i-klinisk-fas-i-minskar</link>
		<pubDate>Fri, 11 May 2012 11:03:22 +0200</pubDate>
		<category>Biotech Sweden</category>
		<category>Forskning</category>
		<category>Kliniska studier</category>
		<category>Bioteknik</category>
		<category>Ekonomi/Branch</category>
		<category>lif</category>
		<category>anders blanck</category>
		<category>varje</category>
		<category>astra zeneca</category>
		<category>l&#228;kemedelsindustrin</category>
		<category>l&#228;kemedelsverket</category>
		<category>quintiles</category>
		</item>
<item>
	<guid>http://biotech.idg.se/2.1763/1.447831/olika-bud-angaende-trenden-med-kliniska-provningar</guid><title>Olika bud ang&#229;ende trenden med kliniska pr&#246;vningar</title>
		<description>Trots att L&#228;kemedelsverkets siffror visar att nedg&#229;ngen i kliniska pr&#246;vningar har planat ut, &#228;r Lif oroade &#246;ver utvecklingen. I sin FoU-enk&#228;t efterlyser de fler &#229;tg&#228;rder. &#160;</description>
		<link>http://biotech.idg.se/2.1763/1.447831/olika-bud-angaende-trenden-med-kliniska-provningar</link>
		<pubDate>Fri, 11 May 2012 11:03:26 +0200</pubDate>
		<category>Biotech Sweden</category>
		<category>Forskning</category>
		<category>Kliniska studier</category>
		<category>Bioteknik</category>
		<category>Ekonomi/Branch</category>
		<category>lifs fou</category>
		<category>l&#228;kemedelsverket</category>
		<category>anders blanck</category>
		<category>biotech sweden</category>
		<category>gunilla andrew-nielsen</category>
		<category>lif</category>
		</item>
<item>
	<guid>http://biotech.idg.se/2.1763/1.438712/nedgangen-har-planat-ut</guid><title>Nedg&#229;ngen har planat ut</title>
		<description>&#60;img src=&#34;http://biotech.idg.se/polopoly_fs/1.438712.1336726369!teaserImage/imageTypeSelector/localImage/1181034601.jpg&#34; border=&#34;0&#34;&#62;&#60;br&#62;De senaste &#229;rens tapp i kliniska pr&#246;vningar har stannat upp. Antalet studier f&#246;rra &#229;ret var i stort sett detsamma som 2010. </description>
		<link>http://biotech.idg.se/2.1763/1.438712/nedgangen-har-planat-ut</link>
		<pubDate>Mon, 16 Apr 2012 09:37:35 +0200</pubDate>
		<category>Biotech Sweden</category>
		<category>Kliniska studier</category>
		<category>Bioteknik</category>
		<category>Ekonomi/Branch</category>
		<category>iv</category>
		<category>gunilla andrew-nielsen</category>
		<category>gunilla andrew-nilesen</category>
		<category>l&#228;kemedelsverket</category>
		<category>astra zeneca</category>
		<category>quintiles</category>
		<category>big</category>
		<category>l&#228;kemedelverket</category>
		</item>
<item>
	<guid>http://biotech.idg.se/2.1763/1.448261/tummen-upp-for-fisktuggummi</guid><title>Tummen upp f&#246;r fisktuggummi </title>
		<description>&#60;img src=&#34;http://biotech.idg.se/polopoly_fs/1.448261.1336729597!teaserImage/imageTypeSelector/localImage/609152814.jpg&#34; border=&#34;0&#34;&#62;&#60;br&#62;Ska ta bort plack och d&#229;lig andedr&#228;kt.</description>
		<link>http://biotech.idg.se/2.1763/1.448261/tummen-upp-for-fisktuggummi</link>
		<pubDate>Fri, 11 May 2012 11:47:02 +0200</pubDate>
		<category>Biotech Sweden</category>
		<category>Bransch</category>
		<category>Regulatory (myndighetsans&#246;kan, godk&#228;nnande)</category>
		<category>Bioteknik</category>
		<category>Ekonomi/Branch</category>
		<category>enzymaticas</category>
		<category>perizyme</category>
		<category>l&#228;kemedelsverket</category>
		<category>eu</category>
		<category>michael edelborg christensen</category>
		<category>ideon science park</category>
		</item>
<item>
	<guid>http://biotech.idg.se/2.1763/1.447887/sp-vill-omvandla-astra-zenecas-lokaler-till-tva-life-science-institut</guid><title>Astras lokaler kan bli tv&#229; life science-institut </title>
		<description>&#60;img src=&#34;http://biotech.idg.se/polopoly_fs/1.447887.1336656606!teaserImage/imageTypeSelector/localImage/838333187.jpg&#34; border=&#34;0&#34;&#62;&#60;br&#62;SP l&#228;mnar f&#246;rslag p&#229; hur kompetens och resurser kan tillvaratas efter Astra Zenecas nedl&#228;ggning i S&#246;dert&#228;lje.</description>
		<link>http://biotech.idg.se/2.1763/1.447887/sp-vill-omvandla-astra-zenecas-lokaler-till-tva-life-science-institut</link>
		<pubDate>Thu, 10 May 2012 09:52:17 +0200</pubDate>
		<category>Biotech Sweden</category>
		<category>Bransch</category>
		<category>Bioteknik</category>
		<category>Ekonomi/Branch</category>
		<category>sp</category>
		<category>astra zeneca</category>
		<category>krim talia</category>
		<category>s&#246;dert&#228;lje</category>
		<category>scandinavian institute for drug discovery</category>
		<category>life science</category>
		<category>vinnova</category>
		<category>iia</category>
		</item>
<item>
	<guid>http://biotech.idg.se/2.1763/1.448048/svensk-sjukvard-bromsar-utvecklingen-enligt-life-science-branschen</guid><title>V&#229;rden bromsar utvecklingen </title>
		<description>&#60;img src=&#34;http://biotech.idg.se/polopoly_fs/1.448048.1336724159!teaserImage/imageTypeSelector/localImage/851983672.jpg&#34; border=&#34;0&#34;&#62;&#60;br&#62;Sjukv&#229;rden beskrevs som ett stort hinder n&#228;r n&#228;ringsutskottet h&#246;ll utfr&#229;gning i riksdagen i dag om framtiden f&#246;r svensk life science.</description>
		<link>http://biotech.idg.se/2.1763/1.448048/svensk-sjukvard-bromsar-utvecklingen-enligt-life-science-branschen</link>
		<pubDate>Thu, 10 May 2012 15:57:28 +0200</pubDate>
		<category>Biotech Sweden</category>
		<category>Bransch</category>
		<category>Forskning</category>
		<category>Politik</category>
		<category>Bioteknik</category>
		<category>Ekonomi/Branch</category>
		<category>astra zeneca</category>
		<category>vinnova</category>
		<category>thomas hedner</category>
		<category>johan j&#228;rte</category>
		<category>sweden bio</category>
		<category>mats odell</category>
		<category>pfizer</category>
		<category>sahlgrenska</category>
		<category>ingrid petersson</category>
		<category>swedish medtech</category>
		<category>ingela nylund watz</category>
		<category>sveirge</category>
		<category>jonas eriksson</category>
		<category>erik weiman</category>
		<category>anna sandtr&#246;m</category>
		<category>anna lefevre skj&#246;ldebrand</category>
		</item>
<item>
	<guid>http://biotech.idg.se/2.1763/1.447747/svart-att-na-nya-marknader</guid><title>Sv&#229;rt att n&#229; nya marknader </title>
		<description>&#60;img src=&#34;http://biotech.idg.se/polopoly_fs/1.447747.1336550565!teaserImage/imageTypeSelector/localImage/3248018053.jpg&#34; border=&#34;0&#34;&#62;&#60;br&#62;D&#228;rf&#246;r lyckas inte bolagen bli framg&#229;ngsrika efter sin internationalisering&#160;</description>
		<link>http://biotech.idg.se/2.1763/1.447747/svart-att-na-nya-marknader</link>
		<pubDate>Wed, 9 May 2012 10:02:04 +0200</pubDate>
		<category>Biotech Sweden</category>
		<category>Bransch</category>
		<category>Jobb &#38; Karri&#228;r</category>
		<category>Bioteknik</category>
		<category>Ekonomi/Branch</category>
		<category>angelika lindstrand</category>
		<category>handelsh&#246;gskolan</category>
		<category>stanford</category>
		<category>tillv&#228;xtverket</category>
		<category>uppsalaklustret</category>
		<category>sting</category>
		<category>mannheim</category>
		<category>olof berglund</category>
		</item>
<item>
	<guid>http://biotech.idg.se/2.1763/1.447750/satsade-internationellt-direkt</guid><title>Atlas Antibodies satsade internationellt direkt</title>
		<description>N&#228;r Atlas Antibodies kommersialiserade sina produkter gick de inte via den svenska marknaden. Detta trots begr&#228;nsad kunskap om export och en liten marknadsf&#246;ringsbudget.</description>
		<link>http://biotech.idg.se/2.1763/1.447750/satsade-internationellt-direkt</link>
		<pubDate>Wed, 9 May 2012 10:02:06 +0200</pubDate>
		<category>Biotech Sweden</category>
		<category>Jobb &#38; Karri&#228;r</category>
		<category>Bioteknik</category>
		<category>Ekonomi/Branch</category>
		<category>atlas antibodies</category>
		<category>marianne hansson</category>
		<category>human protein atlas</category>
		<category>hpa</category>
		</item>
<item>
	<guid>http://biotech.idg.se/2.1763/1.447531/sodertalje-tillsatter-egen-samordnare</guid><title>S&#246;dert&#228;lje utser egen samordnare</title>
		<description>&#60;img src=&#34;http://biotech.idg.se/polopoly_fs/1.447531.1336463934!teaserImage/imageTypeSelector/localImage/669774214.jpg&#34; border=&#34;0&#34;&#62;&#60;br&#62;Ska driva kommunens intressen. </description>
		<link>http://biotech.idg.se/2.1763/1.447531/sodertalje-tillsatter-egen-samordnare</link>
		<pubDate>Tue, 8 May 2012 09:57:02 +0200</pubDate>
		<category>Biotech Sweden</category>
		<category>Jobb &#38; Karri&#228;r</category>
		<category>Bioteknik</category>
		<category>Ekonomi/Branch</category>
		<category>sdertlje</category>
		<category>astra zeneca</category>
		<category>lars leijonborg</category>
		<category>anitra steen</category>
		<category>systembolaget</category>
		</item>
<item>
	<guid>http://biotech.idg.se/2.1763/1.447388/sensidose-rustar-for-framtiden</guid><title>Sensidose rustar f&#246;r framtiden</title>
		<description>&#60;img src=&#34;http://biotech.idg.se/polopoly_fs/1.447388.1336488917!teaserImage/imageTypeSelector/localImage/1786126340.jpg&#34; border=&#34;0&#34;&#62;&#60;br&#62;Ny vd och nya pengar ska ta bolaget fram&#229;t.</description>
		<link>http://biotech.idg.se/2.1763/1.447388/sensidose-rustar-for-framtiden</link>
		<pubDate>Tue, 8 May 2012 17:01:39 +0200</pubDate>
		<category>Biotech Sweden</category>
		<category>Bransch</category>
		<category>Jobb &#38; Karri&#228;r</category>
		<category>Vd-kollen</category>
		<category>Bioteknik</category>
		<category>Ekonomi/Branch</category>
		<category>sensidose</category>
		<category>jack spira</category>
		<category>karolinska institutet</category>
		<category>s&#246;ren nygren</category>
		<category>parkinson</category>
		<category>pharmacia</category>
		</item>
<item>
	<guid>http://biotech.idg.se/2.1763/1.447588/datorspelare-hittar-malaria</guid><title>Dataspel hj&#228;lp vid malariadiagnoser </title>
		<description>&#60;img src=&#34;http://biotech.idg.se/polopoly_fs/1.447588.1336551422!teaserImage/imageTypeSelector/localImage/1031502157.jpg&#34; border=&#34;0&#34;&#62;&#60;br&#62;Hj&#228;lper l&#228;kare att identifiera malariaparasiter i blodet.</description>
		<link>http://biotech.idg.se/2.1763/1.447588/datorspelare-hittar-malaria</link>
		<pubDate>Tue, 8 May 2012 12:36:25 +0200</pubDate>
		<category>Biotech Sweden</category>
		<category>Bio-IT</category>
		<category>Bransch</category>
		<category>Forskning</category>
		<category>Bioteknik</category>
		<category>Ekonomi/Branch</category>
		<category>malariadiagnoser</category>
		<category>ucla</category>
		<category>diagnos</category>
		<category>malaria</category>
		<category>dataspel</category>
		</item>
<item>
	<guid>http://biotech.idg.se/2.1763/1.447298/osaker-framtid-nar-invest-sweden-laggs-ner</guid><title>Os&#228;ker framtid n&#228;r Invest Sweden l&#228;ggs ner</title>
		<description>&#60;img src=&#34;http://biotech.idg.se/polopoly_fs/1.447298.1336383010!teaserImage/imageTypeSelector/localImage/1339116162.jpg&#34; border=&#34;0&#34;&#62;&#60;br&#62;Regeringens f&#246;rslag om att Invest Sweden ska sl&#229;s ihop med Exportr&#229;det m&#246;ts med oro. Fr&#229;gan &#228;r hur fr&#228;mjandet av investeringar inom life science-branschen kommer att fungera i framtiden. </description>
		<link>http://biotech.idg.se/2.1763/1.447298/osaker-framtid-nar-invest-sweden-laggs-ner</link>
		<pubDate>Mon, 7 May 2012 11:30:02 +0200</pubDate>
		<category>Biotech Sweden</category>
		<category>Bransch</category>
		<category>Bioteknik</category>
		<category>Ekonomi/Branch</category>
		<category>invest sweden</category>
		<category>sweden bio</category>
		<category>exportrdet</category>
		<category>peter bramberg</category>
		<category>export</category>
		<category>johan j&#228;rte</category>
		<category>alkem</category>
		<category>karo bio</category>
		<category>kemwells</category>
		<category>pfizer</category>
		</item>
</channel>
</rss>
